Endothelium-derived inhibitors efficiently attenuate the aggregation and adhesion responses of refrigerated platelets

Shock

Volumn 45, Issue 2, 2016, Pages 220-227

  Reddoch, Kristin M ^a,b   Montgomery, Robbie K ^a   Rodriguez, Armando C ^a   Meledeo, M Adam ^a   Pidcoke, Heather F ^b   Ramasubramanian, Anand K ^a   Cap, Andrew P ^b  

^a The University of Texas at San Antonio   (United States)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

Apheresis Platelets; Cold Storage; Hemostatic Function; Inhibition

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BLOOD CLOTTING FACTOR 5; CALCIUM; COLLAGEN; CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE; PADGEM PROTEIN; PROSTACYCLIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; ANTITHROMBOCYTIC AGENT;

APHERESIS; ARTERY BLOOD FLOW; ARTICLE; BLOOD CLOTTING; CALCIUM CELL LEVEL; CRYOPRESERVATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; BLOOD STORAGE; DRUG EFFECTS; METABOLISM; REFRIGERATION; THROMBOCYTE;

BLOOD PLATELETS; BLOOD PRESERVATION; EPOPROSTENOL; FACTOR V; HUMANS; NITRIC OXIDE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; REFRIGERATION;

EID: 84957821838     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000493     Document Type: Article

References (35)

1. Slichter SJ: Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program; 2007;(1):172-178, 2007.
2. Stroncek DF, Rebulla P: Platelet transfusions. Lancet 370(9585):427-438, 2007.
3. Seghatchian J, Krailadsiri P: Platelet storage lesion and apoptosis: are they related? Transfus Apher Sci 24(1):103-105, 2001.
4. Becker GA, Tuccelli M, Kunicki T, Chalos MK, Aster RH: Studies of platelet concentrates stored at 22-C and 4-C. Transfusion 13(2):61-68, 1973.
5. Mcgill M, Brindley DC: Effects of storage on platelet reactivity to arterial subendothelium during blood-flow. J Lab Clin Med 94(2):370-380, 1979.
6. Pidcoke HF, Spinella PC, Ramasubramanian AK, Strandenes G, Hervig T, Ness PM, Cap AP: Refrigerated platelets for the treatment of acute bleeding: a review of the literature and reexamination of current standards. Shock 41(Suppl 1): 51-53, 2014.
7. Reddoch KM, Pidcoke HF, Montgomery RK, Fedyk CG, Aden JK, Ramasubramanian AK, Cap AP: Hemostatic function of apheresis platelets stored at 4 °C and 22 °C. Shock 41(Suppl 1):54-61, 2014.
8. Mitchell JA, Ali F, Bailey L, Moreno L, Harrington LS: Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp Physiol 93(1):141-147, 2008.
9. Kuchan MJ, Jo H, Frangos JA: Role of G proteins in shear stress-mediated nitric oxide production by endothelial cells. Am J Physiol 267(3 Pt 1):C753-C758, 1994.
10. Antl M, von Bruhl ML, Eiglsperger C,Werner M, Konrad I, Kocher T,Wilm M, Hofmann F, Massberg S, Schlossmann J: IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 109(2):552-559, 2007.
11. Sagripanti A, Carpi A: Antithrombotic and prothrombotic activities of the vascular endothelium. Biomed Pharmacother 54(2):107-111, 2000.
12. Sammak PJ, Hinman LE, Tran PO, Sjaastad MD, Machen TE: How do injured cells communicate with the surviving cell monolayer? J Cell Sci 110(Pt 4):465-475, 1997.
13. Shrivastava M: The platelet storage lesion. Transfus Apheresis Sci 41(2):105-113, 2009.
14. Kobsar A, Putz E, Yilmaz P, Weinig E, Boeck M, Koessler J: Decreasing phosphodiesterase 5A activity contributes to platelet cGMP accumulation during storage of apheresis-derived platelet concentrates. Transfusion 54(4):1008-1014, 2014.
15. Higgs EA, Higgs GA, Moncada S, Vane JR: Prostacyclin (PGI(2)) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch (Reprinted from Brit J Pharmacol, vol 63, pg 535-539, 1978). Brit J Pharmacol 120(4):439-443, 1997.
16. Roberts W, Riba R, Homer-Vanniasinkam S, Farndale RW, Naseem KM: Nitric oxide specifically inhibits integrin-mediated platelet adhesion and spreading on collagen. J Thromb Haemost 6(12):2175-2185, 2008.
17. Hemker HC: Calibrated automated thrombinography (CAT). Thromb Res 115(3):255, 2005.
18. Gyulkhandanyan AV, Mutlu A, Allen DJ, Freedman J, Leytin V: BH3-mimetic ABT-737 induces strong mitochondrial membrane depolarization in platelets but only weakly stimulates apoptotic morphological changes, platelet shrinkage and microparticle formation. Thromb Res 133(1):73-79, 2014.
19. Pai M, Wang G, Moffat KA, Liu Y, Seecharan J,Webert K, Heddle N, Hayward C: Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol 136(3):350-358, 2011.
20. Armstrong PCJ, Truss NJ, Ali FY, Dhanji AA, Vojnovic I, Zain ZNM, Bishop-Bailey D, Paul-Clark MJ, Tucker AT, Mitchell JA, et al.: Aspirin and the in vitro linear relationship between thromboxane A(2)-mediated platelet aggregation and platelet production of thromboxane A(2). J Thromb Haemost 6(11):1933-1943, 2008.
21. di Villa Bianca R, Mitidieri E, Mirone V, Fusco F, Imbimbo C, Cirino G, Sorrentino R: An ex vivo standardized assay to measure human platelet cGMP. J Pharmacol Toxicol Methods 64(2):164-167, 2011.
22. Chantarangkul V, Clerici M, Bressi C, Giesen PL, Tripodi A: Thrombin generation assessed as endogenous thrombin potential in patients with hyperor hypo-coagulability. Haematologica 88(5):547-554, 2003.
23. Tarandovskiy ID, Artemenko EO, Panteleev MA, Sinauridze EI, Ataullakhanov FI: Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma. mechanism and possible applications. PLoS One 8(2):e55688, 2013.
24. Hemker HC, Al Dieri R, Beguin S: Thrombin generation assays: accruing clinical relevance. Curr Opin Hematol 11(3):170-175, 2004.
25. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL: Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 95(5):1694-1702, 2000.
26. Berndt MC: On the origin of platelet factor V. Blood 102(8):2712-2713, 2003.
27. Miller MR, Megson IL: Recent developments in nitric oxide donor drugs. Br J Pharmacol 151(3):305-321, 2007.
28. Radomski MW, Palmer RMJ, Moncada S: Comparative pharmacology of endothelium-derived relaxing factor, nitric-oxide and prostacyclin in platelets. Br J Pharmacol 92(1):181-187, 1987.
29. Velik-Salchner C, Maier S, Innerhofer P, StreifW, Klingler A, Kolbitsch C, Fries D: Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Anesth Analg 107(6):1798-1806, 2008.
30. Nair PM, Pidcoke HF, Cap AP, Ramasubramanian AK: Effect of cold storage on shear-induced platelet aggregation and clot strength. J Trauma Acute Care Surg 77(3 Suppl 2):S88-S93, 2014.
31. Aleman MM, Gardiner C, Harrison P,Wolberg AS: Differential contributions of monocyte-and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost 9(11):2251-2261, 2011.
32. Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, et al.: Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets. Transfusion 55(3):507-521, 2015.
33. Varga-Szabo D, Braun A, Nieswandt B: Calciumsignaling in platelets. J Thromb Haemost 7(7):1057-1066, 2009.
34. Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Balbo A, Trovati M: Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. Thromb Res 105(1):71-78, 2002.
35. Tateson JE, Moncada S, Vane JR: Effects of prostacyclin (PGX) on cyclic-AMP concentrations in human platelets. Prostaglandins 13(3):389-397, 1977.